rewirebio.iobenchmarks
Configuration

EricScript v0.5.5 (Tamura et al. 2026)

EricScript v0.5.5: Default parameters; alignment method Multiple; aligner BWA v0.7.17, BLAT v37x1; GRCh38; filtered output used where available.

4 evaluations · 24 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for EricScript v0.5.5 (Tamura et al. 2026). Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluated Checkpoint: v0.5.5

Evaluations and results

4 evaluations · 24 results. Different protocols are not a single leaderboard.

Sorted by F1 (all fusions, conventional RNA-seq of cell lines) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetF1 (all fusions, conventional RNA-seq of cell lines)F1 (all fusions, targeted RNA-seq of cell lines)F1 (driver fusions, conventional RNA-seq of cell lines)F1 (driver fusions, targeted RNA-seq of cell lines)False negatives (all fusions, conventional RNA-seq of cell lines)False negatives (all fusions, targeted RNA-seq of cell lines)False negatives (driver fusions, conventional RNA-seq of cell lines)False negatives (driver fusions, targeted RNA-seq of cell lines)False positives (all fusions, conventional RNA-seq of cell lines)False positives (all fusions, targeted RNA-seq of cell lines)False positives (driver fusions, conventional RNA-seq of cell lines)False positives (driver fusions, targeted RNA-seq of cell lines)Precision (all fusions, conventional RNA-seq of cell lines)Precision (all fusions, targeted RNA-seq of cell lines)Precision (driver fusions, conventional RNA-seq of cell lines)Precision (driver fusions, targeted RNA-seq of cell lines)Recall (all fusions, conventional RNA-seq of cell lines)Recall (all fusions, targeted RNA-seq of cell lines)Recall (driver fusions, conventional RNA-seq of cell lines)Recall (driver fusions, targeted RNA-seq of cell lines)True positives (all fusions, conventional RNA-seq of cell lines)True positives (all fusions, targeted RNA-seq of cell lines)True positives (driver fusions, conventional RNA-seq of cell lines)True positives (driver fusions, targeted RNA-seq of cell lines)
EricScript v0.5.5 (Tamura et al. 2026)EvaluationAll fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3), CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)0.01Not reportedNot reportedNot reported665Not reportedNot reportedNot reported160,271Not reportedNot reportedNot reported0Not reportedNot reportedNot reported0.54Not reportedNot reportedNot reported785Not reportedNot reportedNot reported
EricScript v0.5.5 (Tamura et al. 2026)EvaluationAll fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3), Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)Not reported0.23Not reportedNot reportedNot reported123Not reportedNot reportedNot reported422Not reportedNot reportedNot reported0.16Not reportedNot reportedNot reported0.39Not reportedNot reportedNot reported80Not reportedNot reported
EricScript v0.5.5 (Tamura et al. 2026)EvaluationDriver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5), CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)Not reportedNot reported0.89Not reportedNot reportedNot reported12Not reportedNot reportedNot reported0Not reportedNot reportedNot reported1Not reportedNot reportedNot reported0.8Not reportedNot reportedNot reported49Not reported
EricScript v0.5.5 (Tamura et al. 2026)EvaluationDriver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5), Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)Not reportedNot reportedNot reported0.91Not reportedNot reportedNot reported4Not reportedNot reportedNot reported0Not reportedNot reportedNot reported1Not reportedNot reportedNot reported0.83Not reportedNot reportedNot reported20
All 24 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.01 F1 (all fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'F1' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
665 False negatives (all fusions, conventional RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'False negative' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
160,271 False positives (all fusions, conventional RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'False positive' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0 Precision (all fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'Positive predictive value' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.54 Recall (all fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'True positive rate' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
785 True positives (all fusions, conventional RNA-seq of cell lines)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'True positive' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.23 F1 (all fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'F1' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
123 False negatives (all fusions, targeted RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'False negative' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
422 False positives (all fusions, targeted RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'False positive' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.16 Precision (all fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'Positive predictive value' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.39 Recall (all fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'True positive rate' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
80 True positives (all fusions, targeted RNA-seq of cell lines)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'True positive' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.89 F1 (driver fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'F1' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
12 False negatives (driver fusions, conventional RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'False negative' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0 False positives (driver fusions, conventional RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'False positive' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
1 Precision (driver fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'Positive predictive value' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.8 Recall (driver fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'True positive rate' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
49 True positives (driver fusions, conventional RNA-seq of cell lines)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'EricScript', column 'True positive' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.91 F1 (driver fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'F1' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
4 False negatives (driver fusions, targeted RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'False negative' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0 False positives (driver fusions, targeted RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'False positive' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
1 Precision (driver fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'Positive predictive value' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.83 Recall (driver fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'True positive rate' (PDF page text)
Configuration: EricScript v0.5.5 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
20 True positives (driver fusions, targeted RNA-seq of cell lines)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

EricScript on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'EricScript', column 'True positive' (PDF page text)

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Use this configuration

How it works, versions and access

Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

3 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Facets: method types
1 values
  • supervised_machine_learning
Individual claims
Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript

Original source ↗

Benelli et al. 2012 section 2.6: "we trained an AdaBoost classifier"; section 2.6.4: the classifier, trained with synthetic data, gives the EricScore that ranks candidate fusions

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Bioinformatics 28(24):3232-3239, published 2012-12-01 (version of record, publisher HTML full text)
Retrieved: 2026-10-12T13:36:00Z

conflicting claim

["source-hash-verification","automated-source-review"] · 2026-10-12

Audit details

Correct the method type from conventional_pipeline to supervised_machine_learning (use-case baseline review 2026-10-12, table 1). Issue #121's locator (Tamura 2026 supplement) is wrong: it does not mention AdaBoost. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. Section 2.6: "we trained an AdaBoost classifier" on the GJS, ES and US scores; Section 2.6.4: trained with synthetic data, it gives the EricScore. EricScript remains an alignment-based caller whose candidates are ranked by this learned score. See docs/reviews/2026-10-12-method-type-corrections.md.

Conflicting source claim: "[\"supervised_machine_learning\"]". Claim record status: source_checked.

Field: facets.method_types

Claim: metadata-correction-tags-20261012-252da1e1ea4c4be9003b

Source artifact SHA-256: 6f5f3d171c30b89fc4889a15790bb3af1dc7a038e38ee289d062a394bf4ad61b

Hash scope: OUP refuses scripted downloads (HTTP 403 for the PDF and the HTML, from curl and from an in-page fetch). The hash is the SHA-256 of the UTF-8 innerText (44,359 bytes) of the element .article-body in the article page as rendered in Chrome on 2026-10-12. It describes one retrieval and depends on the browser's text rendering; it is not a hash of publisher bytes. Bibliographic data checked against Crossref (10.1093/bioinformatics/bts617) and Europe PMC (PMID 23093608, not in PMC).

Inspected artifact

Extraction artifact SHA-256: 6f5f3d171c30b89fc4889a15790bb3af1dc7a038e38ee289d062a394bf4ad61b

Extraction artifact

Facets: method types
1 values
  • supervised_machine_learning
Individual claims
Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies

Original source ↗

Benelli et al. 2012 section 2.6: "we trained an AdaBoost classifier"; section 2.6.4: the classifier, trained with synthetic data, gives the EricScore that ranks candidate fusions

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: NPJ Precision Oncology 10:199, published 2026-04-04; PMC13230599 full-text XML
Retrieved: 2026-10-09T20:37:17Z

conflicting claim

["source-hash-verification","automated-source-review"] · 2026-10-12

Audit details

Correct the method type from conventional_pipeline to supervised_machine_learning (use-case baseline review 2026-10-12, table 1). Issue #121's locator (Tamura 2026 supplement) is wrong: it does not mention AdaBoost. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. Section 2.6: "we trained an AdaBoost classifier" on the GJS, ES and US scores; Section 2.6.4: trained with synthetic data, it gives the EricScore. EricScript remains an alignment-based caller whose candidates are ranked by this learned score. See docs/reviews/2026-10-12-method-type-corrections.md.

Conflicting source claim: "[\"supervised_machine_learning\"]". Claim record status: source_checked.

Field: facets.method_types

Claim: metadata-correction-tags-20261012-252da1e1ea4c4be9003b

Source artifact SHA-256: 540cf971970ad98557f3d4511f09c3f06a1b4359fe9276a25e29e731e36c0fc1

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Extraction artifact SHA-256: 6f5f3d171c30b89fc4889a15790bb3af1dc7a038e38ee289d062a394bf4ad61b

Extraction artifact

Facets: method types
1 values
  • supervised_machine_learning
Individual claims
Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12)

Original source ↗

Benelli et al. 2012 section 2.6: "we trained an AdaBoost classifier"; section 2.6.4: the classifier, trained with synthetic data, gives the EricScore that ranks candidate fusions

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 41698_2026_1397_MOESM1_ESM.pdf as served by the publisher
Retrieved: 2026-10-09T20:37:37Z

conflicting claim

["source-hash-verification","automated-source-review"] · 2026-10-12

Audit details

Correct the method type from conventional_pipeline to supervised_machine_learning (use-case baseline review 2026-10-12, table 1). Issue #121's locator (Tamura 2026 supplement) is wrong: it does not mention AdaBoost. Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. Section 2.6: "we trained an AdaBoost classifier" on the GJS, ES and US scores; Section 2.6.4: trained with synthetic data, it gives the EricScore. EricScript remains an alignment-based caller whose candidates are ranked by this learned score. See docs/reviews/2026-10-12-method-type-corrections.md.

Conflicting source claim: "[\"supervised_machine_learning\"]". Claim record status: source_checked.

Field: facets.method_types

Claim: metadata-correction-tags-20261012-252da1e1ea4c4be9003b

Source artifact SHA-256: f18ada098fd03b0842c63a8ab9d13002e1876b006243e42c640a118ea3ab3275

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Extraction artifact SHA-256: 6f5f3d171c30b89fc4889a15790bb3af1dc7a038e38ee289d062a394bf4ad61b

Extraction artifact

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID rna-fusion-20261009-config-tamura2026-ericscript.

Source locator: Supplementary Table 1; Methods 'Detection of gene fusions by each algorithm'

Related records

How to cite

EricScript v0.5.5 (Tamura et al. 2026). Rewire biological model benchmark database, release 2026-11-21-adc15377fab2. https://benchmarks.rewirebio.io/database/configuration/rna-fusion-20261009-config-tamura2026-ericscript/

Release 2026-11-21-adc15377fab2. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction